Measures of costs and benefits for drugs in cost-effectiveness analysis
Year of publication: |
2007
|
---|---|
Authors: | Pauly, Mark V. |
Published in: |
Pharmaceutical innovation : incentives, competition, and cost-benefit analysis in international perspective. - Cambridge [u.a.] : Cambridge Univ. Press, ISBN 0-521-87490-4. - 2007, p. 199-214
|
Subject: | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Kosten-Nutzen-Analyse | Cost-benefit analysis | Gesundheitskosten | Health care costs | Arzneimittel | Pharmaceuticals |
-
A model-based perspective on health economic aspects of osteoporotic fractures
Bleibler, Florian, (2015)
-
Orphan drugs policies : a suitable case for treatment ; editorial
Drummond, Michael F., (2014)
-
Survey of pharmacoeconomic assessment activity in eleven countries
Dickson, Michael, (2003)
- More ...
-
Responsible Tax Credits for Health Insurance
Pauly, Mark V., (2001)
-
Tax Credits, the Distribution of Subsidized Health Insurance Premiums, and the Uninsured
Pauly, Mark V., (2002)
-
Adverse Selection and the Challenges to Stand-Alone Prescription Drug Insurance
Pauly, Mark V., (2004)
- More ...